+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Electrophysiological Evidence for a Sex Difference in Neural Regulation of Prolactin Secretion in Rats

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Prolactin (PRL) secretion patterns were determined in freely moving male and female rats chronically fitted with electrodes in the sexually dimorphic component of the medial preoptic area (MPOA) and the median eminence (ME), together with a chronic atrial blood sampling catheter. Electrodes made of stainless steel or platinum-iridium were implanted bilaterally. Female rats with 4 electrodes in the ME exhibited an attenuated surge of PRL secretion on proestrus (injured group), rats with 2 electrodes in the ME had a normal proestrous surge (intact group). Basal PRL levels were not different between the two groups. Stimulation (100-Hz voltage pulses, 0.2 ms width, 10 s on/5 s off, total duration 25 min) did not produce lesions. Evidence is presented that experimentation was performed without stress. Electrical stimulation applied to the MPOA increased PRL secretion in males, decreased PRL secretion in proestrous females and was without effect in conscious or anesthetized diestrous females. Electrical stimulation applied to different locations of the ME was without effect in male and diestrous female rats; it reduced PRL secretion in proestrous females. These data demonstrate that the MPOA has a sexually differentiated function in the regulation of PRL secretion. The data do not provide evidence for a sexual dimorphism in prolactin-inhibiting factor and prolactin-releasing factor activity in the ME.

          Related collections

          Author and article information

          S. Karger AG
          01 April 2008
          : 44
          : 4
          : 475-482
          Department of Animal Physiology, Agricultural University, Wageningen, The Netherlands
          124689 Neuroendocrinology 1986;44:475–482
          © 1986 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Original Paper


          Comment on this article